Targeting human CD2 by the monoclonal antibody CB.219 reduces intestinal inflammation in a humanized transfer colitis model.

[1]  C. Loddenkemper,et al.  A guide to histomorphological evaluation of intestinal inflammation in mouse models. , 2014, International journal of clinical and experimental pathology.

[2]  Zhanju Liu,et al.  Potential Role of NK Cells in the Pathogenesis of Inflammatory Bowel Disease , 2011, Journal of biomedicine & biotechnology.

[3]  F. Caprioli,et al.  T-cell-directed therapies in inflammatory bowel diseases. , 2010, Clinical science.

[4]  P. Krause,et al.  Regulatory T-cell stability and plasticity in mucosal and systemic immune systems , 2010, Mucosal Immunology.

[5]  Ryan M. O’Connell,et al.  Coordination of tolerogenic immune responses by the commensal microbiota. , 2010, Journal of autoimmunity.

[6]  F. Fava,et al.  Crohn's disease: bacterial clearance in Crohn's disease pathogenesis. , 2010, Nature reviews. Gastroenterology & hepatology.

[7]  F. Powrie,et al.  Mouse models of intestinal inflammation as tools to understand the pathogenesis of inflammatory bowel disease , 2009, European journal of immunology.

[8]  D. Adkins,et al.  Safety Profile and Clinical Outcomes in a Phase I, Placebo-Controlled Study of Siplizumab in Acute Graft-Versus-Host Disease , 2009, Transplantation.

[9]  M. Zeitz,et al.  In vivo Proliferation of Rat Lamina Propria T Lymphocytes: General Hyporesponsiveness but Increased Importance of the CD2 and CD28 Pathways , 2009, Immunological investigations.

[10]  D. Hoskin,et al.  Impaired Interleukin-2 Synthesis and T Cell Proliferation Following Antibody-mediated CD3 and CD2 or CD28 Cross-linking in Trans: Evidence that T Cell Activation Requires the Engagement of Costimulatory Molecules Within the Immunological Synapse , 2008, Immunological investigations.

[11]  C. Loddenkemper,et al.  Aggravation of different types of experimental colitis by depletion or adhesion blockade of neutrophils. , 2007, Gastroenterology.

[12]  S. Saidman,et al.  Regulatory T-cell recovery in recipients of haploidentical nonmyeloablative hematopoietic cell transplantation with a humanized anti-CD2 mAb, MEDI-507, with or without fludarabine. , 2007, Experimental hematology.

[13]  K. Wittkowski,et al.  Alefacept (anti-CD2) causes a selective reduction in circulating effector memory T cells (Tem) and relative preservation of central memory T cells (Tcm) in psoriasis , 2007, Journal of Translational Medicine.

[14]  F. Powrie,et al.  Characterization of Foxp3+CD4+CD25+ and IL-10-Secreting CD4+CD25+ T Cells during Cure of Colitis1 , 2006, The Journal of Immunology.

[15]  F. Powrie,et al.  Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation , 2006, Immunological reviews.

[16]  F. Powrie,et al.  Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology. , 2006, Immunity.

[17]  M. Zeitz,et al.  Lamina propria T cell activation: role of the costimulatory molecule CD2 and its cytoplasmic tail for the regulation of proliferation and apoptosis , 2006, International Journal of Colorectal Disease.

[18]  A. Sharpe,et al.  CD48 controls T-cell and antigen-presenting cell functions in experimental colitis. , 2006, Gastroenterology.

[19]  C. Loddenkemper,et al.  αCD2 mAb treatment safely attenuates adoptive transfer colitis , 2005, Laboratory Investigation.

[20]  Clemens Utzny,et al.  Immunological synapses are versatile structures enabling selective T cell polarization. , 2005, Immunity.

[21]  S. Saidman,et al.  Anti‐tumour response despite loss of donor chimaerism in patients treated with non‐myeloablative conditioning and allogeneic stem cell transplantation , 2005, British journal of haematology.

[22]  E. Hodak,et al.  Alefacept: a review of the literature and practical guidelines for management , 2004, Dermatologic therapy.

[23]  Herren Wu,et al.  Analysis of human and primate CD2 molecules by protein sequence and epitope mapping with anti-human CD2 antibodies. , 2004, Molecular immunology.

[24]  E. Reinherz,et al.  CD2 engagement induces dendritic cell activation: implications for immune surveillance and T-cell activation. , 2003, Blood.

[25]  James Hope,et al.  Nonmyeloablative haploidentical stem-cell transplantation using anti-CD2 monoclonal antibody (MEDI-507)-based conditioning for refractory hematologic malignancies. , 2003, Transplantation.

[26]  Yen-Ming Hsu,et al.  Alefacept, an Immunomodulatory Recombinant LFA-3/IgG1 Fusion Protein, Induces CD16 Signaling and CD2/CD16-Dependent Apoptosis of CD2+ Cells1 , 2002, The Journal of Immunology.

[27]  H. Groux,et al.  Differentiation of Regulatory T Cells 1 Is Induced by CD2 Costimulation1 , 2001, The Journal of Immunology.

[28]  F. Jamar,et al.  Effects on human and nonhuman primate immune response of a new rat anti-CD2 monoclonal antibody. , 2000, Transplantation.

[29]  Gerhard Wagner,et al.  Structure of a Heterophilic Adhesion Complex between the Human CD2 and CD58 (LFA-3) Counterreceptors , 1999, Cell.

[30]  L. Sehn,et al.  A Phase II Study of BTI-322, a Monoclonal Anti-CD2 Antibody, for Treatment of Steroid-Resistant Acute Graft-Versus-Host Disease , 1998 .

[31]  A. Bernard,et al.  Potent apoptotic signaling and subsequent unresponsiveness induced by a single CD2 mAb (BTI-322) in activated human peripheral T cells. , 1998, Journal of immunology.

[32]  R. Testi,et al.  Stimulated human lamina propria T cells manifest enhanced Fas-mediated apoptosis. , 1996, The Journal of clinical investigation.

[33]  H. Bazin,et al.  An anti-CD2 mAb induces immunosuppression and hyporesponsiveness of CD2+ human T cells in vitro. , 1996, International immunology.

[34]  R. Coffman,et al.  Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice. , 1993, International immunology.

[35]  M. Sandrin,et al.  CD48 is a low affinity ligand for human CD2. , 1993, Journal of immunology.

[36]  K. Kato,et al.  CD48 is a counter-receptor for mouse CD2 and is involved in T cell activation , 1992, The Journal of experimental medicine.

[37]  Susumu Tonegawa,et al.  RAG-1-deficient mice have no mature B and T lymphocytes , 1992, Cell.

[38]  S. Meuer,et al.  Dual function of recombinant human CD58: inhibition of T cell adhesion and activation via the CD2 pathway. , 1991, International immunology.

[39]  S. Meuer,et al.  Differential responsiveness to CD3‐Ti vs. CD2‐dependent activation of human intestinal T lymphocytes , 1990, European journal of immunology.

[40]  R. Siliciano,et al.  Role of interaction of CD2 molecules with lymphocyte function-associated antigen 3 in T-cell recognition of nominal antigen. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[41]  D. Kioussis,et al.  The structure of the human CD2 gene and its expression in transgenic mice. , 1988, The EMBO journal.

[42]  F. Faure,et al.  Identification of a CD2- CD3+ T cell receptor-gamma+ peripheral blood lymphocyte subpopulation. , 1988, Journal of immunology.

[43]  E. Reinherz,et al.  Molecular cloning and expression of T11 cDNAs reveal a receptor-like structure on human T lymphocytes. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[44]  B. Fleischer.  A novel pathway of human T cell activation via a 103 kD T cell activation antigen. , 1987, Journal of immunology.

[45]  P. A. Biro,et al.  Gene mapping and somatic cell hybrid analysis of the role of human lymphocyte function-associated antigen-3 (LFA-3) in CTL-target cell interactions. , 1986, Journal of immunology.

[46]  J. C. Pratt,et al.  Activation of cytolytic T lymphocyte and natural killer cell function through the T11 sheep erythrocyte binding protein , 1985, Nature.

[47]  E. Reinherz,et al.  An alternative pathway of T-cell activation: A functional role for the 50 kd T11 sheep erythrocyte receptor protein , 1984, Cell.

[48]  G. Longton,et al.  Identification and functional characterization of two distinct epitopes on the human T cell surface protein Tp50. , 1983, Journal of immunology.

[49]  R. Blumberg,et al.  The immunology of mucosal models of inflammation. , 2002, Annual review of immunology.